uniQure N.V.

QURE

$38.23

Name : uniQure N.V.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $2,651,878,144.00

EPSttm : -4.06

uniQure N.V.

$38.23

0.23%

$0.09

QURE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

15.39

Margin Of Safety %

Put/Call OI Ratio

0.28

EPS Next Q Diff

0.41

EPS Last/This Y

0.03

EPS This/Next Y

0.8

Price

38.22

Target Price

Analyst Recom

1.23

Performance Q

-19.53

Upside

-470.8%

Beta

1.01

Ticker: QURE

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	QURE	48.69	0.27	0.19	168808
2026-08-31	QURE	48.68	0.27	0.19	169460
2026-09-02	QURE	46.23	0.27	0.44	172586
2026-09-03	QURE	44.85	0.27	0.18	176499
2026-09-04	QURE	44.47	0.28	0.09	177092
2026-09-08	QURE	45.63	0.27	0.12	180096
2026-09-09	QURE	45.97	0.27	0.11	183455
2026-09-10	QURE	44.47	0.26	0.05	186384
2026-09-11	QURE	44.5	0.26	1.00	187726
2026-09-14	QURE	44.89	0.27	0.36	188826
2026-09-15	QURE	43.09	0.27	0.22	189379
2026-09-16	QURE	42.48	0.27	0.50	192552
2026-09-17	QURE	44.08	0.26	0.28	193365
2026-09-18	QURE	43.97	0.26	0.63	194665
2026-09-21	QURE	44.32	0.26	0.21	179262
2026-09-22	QURE	45.28	0.26	0.10	184161
2026-09-23	QURE	42.79	0.25	0.16	188797
2026-09-24	QURE	38.36	0.25	0.61	190478
2026-09-25	QURE	38.2	0.28	0.21	204193
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	QURE	48.77	31.2	-	-3.43
2026-08-31	QURE	48.63	31.2	-	-3.43
2026-09-01	QURE	47.86	31.2	-	-3.43
2026-09-02	QURE	46.20	31.2	-	-3.43
2026-09-03	QURE	44.90	31.2	-	-3.43
2026-09-04	QURE	44.49	31.2	-	-3.43
2026-09-08	QURE	45.65	31.0	-	-3.43
2026-09-09	QURE	45.97	31.0	-	-3.43
2026-09-10	QURE	44.49	31.0	-	-3.43
2026-09-11	QURE	44.51	31.0	-	-3.43
2026-09-14	QURE	44.89	31.1	-	-3.43
2026-09-15	QURE	43.10	31.1	-	-3.43
2026-09-16	QURE	43.10	31.1	-	-3.43
2026-09-17	QURE	44.08	31.1	-	-3.43
2026-09-18	QURE	43.97	31.1	-	-3.43
2026-09-21	QURE	44.33	31.1	-	-3.43
2026-09-22	QURE	45.32	31.1	-	-3.43
2026-09-23	QURE	42.78	31.1	-	-3.43
2026-09-24	QURE	38.31	31.1	-	-3.43
2026-09-25	QURE	38.22	31.1	-	-3.43
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	QURE	-9.60	5.51	16.71
2026-08-31	QURE	-9.60	5.50	16.71
2026-09-01	QURE	-9.60	5.50	16.71
2026-09-02	QURE	-9.59	5.50	16.71
2026-09-03	QURE	-9.59	5.50	16.71
2026-09-04	QURE	-9.60	5.50	16.71
2026-09-08	QURE	-8.11	5.50	16.71
2026-09-09	QURE	-8.11	5.50	16.71
2026-09-10	QURE	-8.11	5.50	16.71
2026-09-11	QURE	-8.11	5.50	15.32
2026-09-14	QURE	-8.11	5.52	15.32
2026-09-15	QURE	-8.11	5.52	15.32
2026-09-16	QURE	-8.11	5.52	15.32
2026-09-17	QURE	-8.11	5.52	15.32
2026-09-18	QURE	-8.11	5.52	15.32
2026-09-21	QURE	-8.11	5.53	15.32
2026-09-23	QURE	-8.11	5.53	15.32
2026-09-24	QURE	-8.11	5.53	15.32
2026-09-25	QURE	-8.11	5.53	15.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-1.22

Avg. EPS Est. Current Quarter

-0.82

Avg. EPS Est. Next Quarter

-0.81

Insider Transactions

-8.11

Institutional Transactions

5.53

Beta

1.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

46.6

Max Drawdown 5-Year %

-89.5

Target Price

P/E

Forward P/E

PEG

P/S

142.04

P/B

8.18

P/Free Cash Flow

EPS

-4.05

Average EPS Est. Cur. Y

-3.43

EPS Next Y. (Est.)

-2.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1350.73

Relative Volume

0.82

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-84.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

◆ QURE Healthcare

$38.23

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

17/25

Volume

7/15

Valuation

12/20

TP/AR

6/10

Options

7/10

RSI

30.9

Range 1M

10.3%

Sup Dist

6.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

11/30

Estimates

5/20

Inst/Vol

5/15

Options

10/10

EPS Yr

-12.5%

EPS NY

22.2%

52W%

47.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +77.9% upside

Quality

3/30

Valuation

12/30

Growth

10/25

Stability

6/10

LT Trend

1/5

Upside

+77.9%

Quality

QURE — P/E HistoricalBiotechnology

uniQure N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 221

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

QURE

Latest News

—

Caricamento notizie per QURE…

stock quote shares QURE – uniQure N.V. Stock Price stock today

news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch QURE – uniQure N.V. yahoo finance google finance

stock history QURE – uniQure N.V. invest stock market

stock prices QURE premarket after hours

ticker QURE fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: QURE

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y